Leucovorin
Showing 1 - 25 of 1,809
Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)
Active, not recruiting
- Autism Spectrum Disorder
- Language Disorders
- Levoleucovorin Calcium
- Placebo
-
Phoenix, Arizona
- +1 more
Sep 26, 2022
Autism Spectrum Disorder, Language Disorders Trial in Phoenix, Brooklyn (Levoleucovorin Calcium, Placebo)
Active, not recruiting
- Autism Spectrum Disorder
- Language Disorders
- Levoleucovorin Calcium
- Placebo
-
Phoenix, Arizona
- +1 more
Oct 7, 2022
Metastatic Pancreatic Cancer Trial (nanoliposomal irinotecan, spleen irradiation)
Not yet recruiting
- Metastatic Pancreatic Cancer
- nanoliposomal irinotecan
- spleen irradiation
- (no location specified)
May 8, 2022
Pancreatic Ductal Adenocarcinoma Trial in United States (Onvansertib, Nanoliposomal irinotecan, Leucovorin)
Recruiting
- Pancreatic Ductal Adenocarcinoma
- Onvansertib
- +3 more
-
Phoenix, Arizona
- +5 more
Dec 15, 2022
Colorectal Cancer, Colorectal Tumors, Colorectal Adenocarcinoma Trial in Worldwide (Fosifloxuridine Nafalbenamide, Leucovorin,
Recruiting
- Colorectal Cancer
- +4 more
- Fosifloxuridine Nafalbenamide
- +4 more
-
Wichita, Kansas
- +5 more
Jan 9, 2023
Gastric Cancer, Gastric Adenocarcinoma, Effects of Chemo Trial in Taiwan (leucovorin, oxaliplatin, docetaxel, S-1)
Recruiting
- Gastric Cancer
- +3 more
- leucovorin, oxaliplatin, docetaxel, S-1
-
Kaohsiung, Taiwan
- +3 more
May 24, 2022
Pancreas Cancer, Metastatic Pancreatic Cancer, Metastatic Pancreatic Adenocarcinoma Trial in Boston (drug, radiation, procedure)
Recruiting
- Pancreas Cancer
- +2 more
- FOLFIRINOX
- +9 more
-
Boston, MassachusettsMassachusetts General Hospital Cancer Center
Aug 19, 2022
Colorectal Cancer Trial in Philadelphia (Regorafenib, 5-FU, Leucovorin)
Terminated
- Colorectal Cancer
- Regorafenib
- +2 more
-
Philadelphia, PennsylvaniaFox Chase Cancer Center
Jan 10, 2022
Gastric Cancer, Stomach Cancer, GastroEsophageal Cancer Trial in Kyiv (Docetaxel, Oxaliplatin, Leucovorin)
Recruiting
- Gastric Cancer
- +10 more
- Docetaxel
- +3 more
-
Kyiv, UkraineNational Cancer Institute
Aug 31, 2023
Pancreatic Cancer, Resectable Pancreatic Cancer, Borderline Resectable Pancreatic Adenocarcinoma Trial in Boston (drug,
Not yet recruiting
- Pancreatic Cancer
- +3 more
- mFOLFIRINOX
- +7 more
-
Boston, Massachusetts
- +1 more
Sep 16, 2022
Colorectal Cancer, Metastatic Cancer Trial in Boulogne Billancourt (FOLFIRI regimen, fluorouracil, irinotecan HCl)
Withdrawn
- Colorectal Cancer
- Metastatic Cancer
- FOLFIRI regimen
- +7 more
-
Boulogne Billancourt, FranceHopital Ambroise Pare
Aug 26, 2022
Advanced Biliary Tract Cancer Trial in Washington, Indianapolis, Saint Louis (Nanoliposomal Irinotecan, Leucovorin,
Recruiting
- Advanced Biliary Tract Cancer
- Nanoliposomal Irinotecan
- +2 more
-
Washington, District of Columbia
- +2 more
Oct 29, 2021
Metastatic Colorectal Cancer Trial (Cetuximab + Envafolimab + mFOLFOXIRI, Cetuximab + mFOLFOX6/FOLFIRI)
Not yet recruiting
- Metastatic Colorectal Cancer
- Cetuximab + Envafolimab + mFOLFOXIRI
- Cetuximab + mFOLFOX6/FOLFIRI
- (no location specified)
Jul 24, 2023
High-risk Stage II Colorectal Cancer, Stage III Colorectal Cancer, Circulating Tumor DNA Methylation Trial in Shanghai
Recruiting
- High-risk Stage II Colorectal Cancer
- +2 more
- mFOLFIRINOX adjuvant chemotherapy
- mFOLFOX6/XELOX adjuvant chemotherapy
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Jul 12, 2023
Borderline Resectable Pancreatic Adenocarcinoma, Locally Advanced Pancreatic Ductal Adenocarcinoma Trial in Los Angeles
Not yet recruiting
- Borderline Resectable Pancreatic Adenocarcinoma
- Locally Advanced Pancreatic Ductal Adenocarcinoma
- Biospecimen Collection
- +9 more
-
Los Angeles, CaliforniaYonemoto,Lisa
Jan 13, 2023
Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI + Cadonilimab, mFOLFOX6)
Not yet recruiting
- Colorectal Cancer
- mFOLFOXIRI + Cadonilimab
- mFOLFOX6
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Oct 17, 2022
Autism Spectrum Disorder Trial in United States (Folinic Acid, Placebo)
Recruiting
- Autism Spectrum Disorder
- Folinic Acid
- Placebo
-
Phoenix, Arizona
- +3 more
Jan 13, 2022
Colorectal Cancer Metastatic Trial in Guangzhou (Dexamethasone, Anisodamine, Oxaliplatin)
Recruiting
- Colorectal Cancer Metastatic
- Dexamethasone
- +6 more
-
Guangzhou, Guangdong, ChinaSun Yat-sen University Cancer Center
Feb 3, 2023
Mucinous Adenocarcinoma of the Rectum, Signet Ring Adenocarcinoma of the Rectum, Stage IIA Rectal Cancer Trial in Los Angeles
Active, not recruiting
- Mucinous Adenocarcinoma of the Rectum
- +7 more
- bevacizumab
- +4 more
-
Los Angeles, CaliforniaUSC Norris Comprehensive Cancer Center
Aug 5, 2022
Biliary Tract Cancer Trial in United States (Nivolumab, Nanoliposomal-Irinotecan, 5-Fluorouracil)
Active, not recruiting
- Biliary Tract Cancer
- Nivolumab
- +3 more
-
Ann Arbor, Michigan
- +4 more
Oct 6, 2022
Colorectal Cancer Trial in Guangzhou (mFOLFOXIRI plus Bevacizumab, mFOLFOX6 Plus Bevacizumab)
Recruiting
- Colorectal Cancer
- mFOLFOXIRI plus Bevacizumab
- mFOLFOX6 Plus Bevacizumab
-
Guangzhou, Guangdong, ChinaGastrointestinal Hospital, Sun Yat-sen University
Jun 15, 2022
Esophageal Carcinoma Trial in Rochester (mFOLFOX6, Chemoradiation)
Active, not recruiting
- Esophageal Carcinoma
- mFOLFOX6
- Chemoradiation
-
Rochester, New YorkUniversity of Rochester
Aug 17, 2022